slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 1,561-1,590
Pages 1,437
Rows per page 30
Arc
1,561-1,590 of 43,093
09
The slide uses a grid of cards to present various metrics related to digital banking performance.Flushing Financial | Investor Presentation Deck | 35 slides · Flushing Financial Corporation
Pitch deck Investor relations Beat · Solution2 hits
04
The slide uses a wave-like visual to represent market segments and their associated financial opportunities.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem2 hits
06
The slide explicitly notes that these are cross-trial comparisons and not head-to-head studies.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem2 hits
07
The slide uses a table structure to contrast standard of care with the company's target segment. The bottom section uses bar charts to imply relative patient population growth.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem2 hits
08
The slide explicitly warns about cross-trial comparison limitations in the footer.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem2 hits
07
Uses a process-flow style diagram to map specific market segments to macro-level value drivers.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
09
The slide uses a comparison framework to contrast two revenue streams.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Beat · Solution2 hits
10
LMM stands for Lower Middle Market.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Problem2 hits
12
The slide uses a visual timeline/process flow to explain the disease progression.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
09
The slide demonstrates superior tumor volume reduction by NXP800 compared to standard-of-care Cisplatin in both SKOV-3 and TOV-21G models.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
10
Includes a patient-derived xenograft (PDX) study workflow diagram and a tumor volume growth curve.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
11
The chart shows tumor volume reduction over 28 days compared to vehicle control.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
12
Clinical trial NCT05226507 status update.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
13
Nuvectis Pharma | Investor Presentation Deck | 23 slidesNuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
14
Nuvectis Pharma | Investor Presentation Deck | 23 slidesNuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
15
The visualization is a standard kinome tree map used in pharmaceutical research to demonstrate drug selectivity.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
16
Uses a structural biology diagram to illustrate mechanism of action.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
17
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
18
The charts demonstrate efficacy in specific cell lines (KYSE70 and Cal27) with known genetic alterations.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
19
Includes two distinct experimental setups: cell proliferation assays and mouse tumor growth models.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
20
Clinical trial identifier NCT05873686 is provided.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
07
The slide uses a hub-and-spoke style diagram to show how various services integrate into a central infrastructure.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Problem2 hits
08
The chart is a donut chart representing the total TAM as the center and segments as the outer ring.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Solution2 hits
06
The slide uses a hub-and-spoke style diagram to show the flow of value between sellers, the platform, and fans.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations Beat · Solution2 hits
07
The slide uses a cloud icon to represent synchronization between desktop and mobile app interfaces.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations Beat · Solution2 hits
08
The slide uses a process flow diagram to map app features to user benefits.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations Beat · Solution2 hits
09
The slide uses a circular flow diagram to represent the business model's self-reinforcing nature.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations Beat · Solution2 hits
10
The slide uses a split-screen layout to contrast the loyalty program (left) and gamified engagement (right).Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations Beat · Solution2 hits
14
The slide uses a color-coded block structure to categorize financial highlights.Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations Beat · Traction2 hits
15
The slide uses a dark theme with distinct color coding for GOV (pink/purple) and Revenue (blue).Vivid Seats | Investor Presentation Deck | 22 slides · Vivid Seats
Pitch deck Investor relations Beat · Traction2 hits